Value Sense
CI
Cigna Corporation (CI)
Last Price$311.50.9%
Market Cap$87.2B
LTM Gross Profit
$119.9B
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
202.7% undervalued
CI
is 202.7% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Cigna Corporation Gross Profit

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross Profit
$18.2B
$16.7B
$16.5B
$17.6B
$19.1B
$18.4B
$21.3B
$22.0B
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
CI
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CI and see if it's the right time to invest.
Dive in

Cigna Corporation (CI) Gross Profit comparison analysis

General

LTM Gross Profit

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Cigna Corporation logo
Cigna CorporationCI
$119.9B
N/A
N/A
N/A
Median Peer Set
$17.8B
34.6%
15.9%
9.5%
Humana Inc. logo
Humana Inc.HUM
$108.2B
12.5%
17.1%
15.7%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
$87.4B
0.6%
7.9%
8.7%
Elevance Health Inc. logo
Elevance Health Inc.ELV
$76.7B
63.2%
28.7%
27.9%
CVS Health Corporation logo
CVS Health CorporationCVS
$51.4B
(5.6%)
(0.4%)
2.5%
Centene Corporation logo
Centene CorporationCNC
$21.4B
(22.2%)
14.7%
19.4%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
$14.1B
225.4%
62.6%
42.1%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
$9,177.6M
56.6%
68.4%
N/A
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
$911.6M
353.5%
92.0%
N/A
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
$739.4M
192.8%
N/A
10.2%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
$126.2M
(80.3%)
(7.6%)
N/A

CI key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
18,176.0
0.0%
16,684.0
(8.2%)
16,547.0
(0.8%)
17,623.0
6.5%
19,101.0
8.4%
18,414.0
(3.6%)
21,253.0
15.4%
21,998.0
3.5%
29,119.0
32.4%
32,380.0
11.2%
34,914.0
7.8%
37,876.0
8.5%
40,007.0
5.6%
42,043.0
5.1%
48,569.0
15.5%
153,743.0
216.5%
160,550.0
4.4%
174,267.0
8.5%
180,031.0
3.3%
195,187.0
8.4%
Cost of Goods Sold (COGS)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Gross Profit
% margin
18,176.0
100.0%
16,684.0
100.0%
16,547.0
100.0%
17,623.0
100.0%
19,101.0
100.0%
18,414.0
100.0%
21,253.0
100.0%
21,998.0
100.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
Operating Expenses(15,940.0)14,891.014,816.015,990.018,719.016,516.019,326.019,989.026,374.00.00.00.036,919.038,101.044,409.0145,666.0152,397.0166,326.0171,581.0186,651.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)0.00.00.00.05,535.05,450.05,744.05,901.00.00.00.00.09,750.09,830.011,141.013,315.013,660.012,791.013,110.014,370.0
Operating Income
% margin
2,236.0
12.3%
1,793.0
10.7%
1,731.0
10.5%
1,626.0
9.2%
382.0
2.0%
1,896.0
10.3%
2,048.0
9.6%
2,169.0
9.9%
2,875.0
9.9%
32,380.0
100.0%
34,914.0
100.0%
37,876.0
100.0%
3,088.0
7.7%
3,942.0
9.4%
4,160.0
8.6%
8,077.0
5.3%
8,153.0
5.1%
7,941.0
4.6%
8,450.0
4.7%
8,536.0
4.4%
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Interest Expense0.00.00.00.00.0166.0182.0202.00.0264.00.00.0278.0252.0498.01,682.01,438.01,208.01,228.01,446.0
Pre-tax Income2,375.01,793.01,731.01,631.0378.01,898.01,870.01,968.02,477.02,176.03,304.03,327.02,979.03,606.03,581.06,570.010,868.06,790.08,397.05,513.0
Income Tax
% effective tax rate
798.0
33.6%
517.0
28.8%
572.0
33.0%
511.0
31.3%
90.0
23.8%
594.0
31.3%
521.0
27.9%
640.0
32.5%
853.0
34.4%
698.0
32.1%
1,210.0
36.6%
1,250.0
37.6%
1,136.0
38.1%
1,374.0
38.1%
935.0
26.1%
1,450.0
22.1%
2,379.0
21.9%
1,370.0
20.2%
1,615.0
19.2%
141.0
2.6%
Net Income
% margin
1,438.0
7.9%
1,625.0
9.7%
1,155.0
7.0%
1,115.0
6.3%
292.0
1.5%
1,302.0
7.1%
1,345.0
6.3%
1,327.0
6.0%
1,623.0
5.6%
1,476.0
4.6%
2,102.0
6.0%
2,094.0
5.5%
1,867.0
4.7%
2,237.0
5.3%
2,637.0
5.4%
5,104.0
3.3%
8,458.0
5.3%
5,370.0
3.1%
6,704.0
3.7%
5,164.0
2.6%
EPS3.514.253.493.941.054.754.694.655.705.287.978.177.318.9210.6913.5823.1715.8921.6617.57
Diluted EPS3.484.173.433.871.054.734.654.595.615.187.838.047.198.7710.5413.4422.9615.7521.4117.39
EBITDA
% margin
2,098.0
11.5%
1,990.0
11.9%
1,895.0
11.5%
1,780.0
10.1%
351.0
1.8%
2,073.0
11.3%
2,343.0
11.0%
2,508.0
11.4%
3,434.0
11.8%
32,977.0
101.8%
35,502.0
101.7%
38,295.0
101.1%
3,472.0
8.7%
4,187.0
10.0%
4,082.0
8.4%
10,916.0
7.1%
14,477.0
9.0%
10,413.0
6.0%
12,908.0
7.2%
9,574.0
4.9%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Cigna Corporation's Gross Profit?

As of today, Cigna Corporation's last 12-month Gross Profit is $119.9B, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Cigna Corporation's Gross Profit growth rate?

Over the last year, Cigna Corporation's Gross Profit growth was N/A. The average annual Gross Profit growth rates for Cigna Corporation have been N/A over the past three years, N/A over the past five years.